146 related articles for article (PubMed ID: 10503729)
61. Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotyping.
Kennedy PT; Phillips N; Chandrasekhar J; Jacobs R; Jacobs M; Dusheiko G
Liver Int; 2008 May; 28(5):699-704. PubMed ID: 18433396
[TBL] [Abstract][Full Text] [Related]
62. Persistent risk for hepatocellular carcinoma after more than a decade of successful hepatitis B virus suppression.
Dargan A; Wong SY; Coben R; Conn M; Dimarino AJ; Hann HW
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):74-76. PubMed ID: 28054479
[No Abstract] [Full Text] [Related]
63. New antiviral agents for the therapy of chronic hepatitis B virus infection.
Zoulim F; Trepo C
Intervirology; 1999; 42(2-3):125-44. PubMed ID: 10516467
[TBL] [Abstract][Full Text] [Related]
64. How does hepatitis B virus infection react to hepatocellular carcinoma treatment?
Wong GL
J Gastroenterol Hepatol; 2012 Jan; 27(1):1-2. PubMed ID: 22188022
[No Abstract] [Full Text] [Related]
65. [Chronic hepatitis B].
Kumada H
Nihon Shokakibyo Gakkai Zasshi; 2001 May; 98(5):503-11. PubMed ID: 11400278
[No Abstract] [Full Text] [Related]
66. Treatment of recurrence of hepatitis B in transplant patients.
Berenguer M; Wright TL
J Hepatol; 2003; 39 Suppl 1():S190-3. PubMed ID: 14708702
[No Abstract] [Full Text] [Related]
67. Symposium on clinical aspects in hepatitis virus infection. 3. Update of liver disease related to chronic hepatitis B virus infection.
Ishikawa T; Kakumu S
Intern Med; 2001 Feb; 40(2):178-9. PubMed ID: 11300161
[No Abstract] [Full Text] [Related]
68. [New management of hepatitis B virus].
Sata M; Kumashiro R
Nihon Naika Gakkai Zasshi; 1999 Apr; 88(4):713-7. PubMed ID: 10341661
[No Abstract] [Full Text] [Related]
69. Much remains to be solved in lamivudine treatment for HBV-associated liver diseases.
Tanikawa K
J Gastroenterol; 2001 Jul; 36(7):515-6. PubMed ID: 11480799
[No Abstract] [Full Text] [Related]
70. Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma.
Persico M; De Marino F; Russo GD; Morante A; Rotoli B; Torella R; De Renzo A
Blood; 2002 Jan; 99(2):724-5. PubMed ID: 11799967
[No Abstract] [Full Text] [Related]
71. Combination therapy for hepatitis B.
Di Bisceglie AM
Gut; 2002 Apr; 50(4):443-5. PubMed ID: 11889057
[TBL] [Abstract][Full Text] [Related]
72. Case records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver.
Tanabe KK; Blaszkowsky LS; Chung RT; Blake MA; Lauwers GY
N Engl J Med; 2005 Jul; 353(4):401-10. PubMed ID: 16049213
[No Abstract] [Full Text] [Related]
73. Combination chemotherapy for hepatitis B virus: the final solution?
Shaw T; Locarnini S
Hepatology; 2000 Aug; 32(2):430-2. PubMed ID: 10915754
[No Abstract] [Full Text] [Related]
74. Lamivudine therapy for chronic hepatitis B virus infection and pregnancy: a case report.
Tomasiewicz K; Modrzewska R; Krawczuk G; Lyczak A
Int J Infect Dis; 2001; 5(2):115-6. PubMed ID: 11468109
[No Abstract] [Full Text] [Related]
75. Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation.
Fischer L; Sterneck M; Zöllner B; Rogiers X
Transplant Proc; 2000 Nov; 32(7):2128-30. PubMed ID: 11120099
[No Abstract] [Full Text] [Related]
76. Virological and histological outcome of a patient with chronic hepatitis B transplanted with liver from hepatitis C virus-positive donor.
Chan HL; Chui AK; Chan FK; Rao AR; Wong J; Lau WY
Transplant Proc; 2003 Feb; 35(1):423-4. PubMed ID: 12591470
[No Abstract] [Full Text] [Related]
77. Role of HBx in hepatitis B virus persistence and its therapeutic implications.
Slagle BL; Bouchard MJ
Curr Opin Virol; 2018 Jun; 30():32-38. PubMed ID: 29454995
[TBL] [Abstract][Full Text] [Related]
78. Hepatitis B virus genotypes and hepatocellular carcinoma in Japan.
Fujie H; Moriya K; Shintani Y; Yotsuyanagi H; Iino S; Koike K
Gastroenterology; 2001 May; 120(6):1564-5. PubMed ID: 11339239
[No Abstract] [Full Text] [Related]
79. Therapy for chronic hepatitis B: the earlier, the better?
Hu J; Nguyen D
Trends Microbiol; 2004 Oct; 12(10):431-3. PubMed ID: 15381188
[No Abstract] [Full Text] [Related]
80. Antiviral T-cell responses and therapy in chronic hepatitis B.
Alatrakchi N; Koziel MJ
J Hepatol; 2003 Oct; 39(4):631-4. PubMed ID: 12971976
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
